Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data

Authors

Institutions

Publication Details

Journal
Advances in Therapy
Published
2025-09-23
DOI
https://doi.org/10.1007/s12325-025-03368-4
Citations
2
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
3.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data

David Trueman, Tara M. Robinson, Sandra Santos
2 citations
Advances in Therapy
Hemophilia Treatment and Research
3.54
article

Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data

David Trueman, Tara M. Robinson, Sandra Santos
article en
2 citations

Abstract

No abstract available for this paper.
Advances in TherapyVol. 42(11)
Office Of Health Economics (GB), BioMarin (United Kingdom) (GB), BioMarin (United States) (US)
Openalex Percentile: Top 6%
Hemophilia Treatment and Research
3.54
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.